Open0.057 | Close- |
Vol / Avg.927.440K / 3.252M | Mkt Cap13.764M |
Day Range0.056 - 0.059 | 52 Wk Range0.046 - 0.860 |
Alaunos Therapeutics Stock (NASDAQ: TCRT) stock price, news, charts, stock research, profile.
Open0.057 | Close- |
Vol / Avg.927.440K / 3.252M | Mkt Cap13.764M |
Day Range0.056 - 0.059 | 52 Wk Range0.046 - 0.860 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.030 | -0.040 | -0.0100 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-16 | HC Wainwright & Co. | Swayampakula Ramakanth | Downgrades | BuyNeutral | - | - | - |
2023-08-15 | Laidlaw & Co. | Yale Jen | Downgrades | BuyHold | - | - | - |
2023-05-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Upgrades | NeutralBuy | Announces | - | 1.50 |
2023-03-27 | Wells Fargo | Yanan Zhu | Assumes | Overweight | Announces | - | 3.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
TCRT | Alaunos Therapeutics | 0% | 14M |
VINC | Vincerx Pharma | -2.18% | 13.8M |
VIRI | Virios Therapeutics | -7.98% | 12.7M |
IMRN | Immuron | -2.38% | 11.7M |
DOMH | Dominari Holdings | 0.36% | 11.7M |
You can purchase shares of Alaunos Therapeutics (NASDAQ: TCRT) through any online brokerage.
Other companies in Alaunos Therapeutics’s space includes: Vincerx Pharma (NASDAQ:VINC), Virios Therapeutics (NASDAQ:VIRI), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by HC Wainwright & Co. on Wednesday, August 16, 2023. The analyst firm set a price target for 0.00 expecting TCRT to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
The stock price for Alaunos Therapeutics (NASDAQ: TCRT) is $0.0582 last updated Today at December 7, 2023 at 2:16 PM UTC.
There is no dividend information for Alaunos Therapeutics.
Alaunos Therapeutics’s Q4 earnings are confirmed for Tuesday, March 5, 2024.
There is no upcoming split for Alaunos Therapeutics.
Alaunos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.